CORSAIR CAPITAL MANAGEMENT, L.P.

Position in HROW — Harrow, Inc.

CIK 1276470 NEW YORK, NY

Back to HROW Full portfolio

Position in HROW

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$806,930

+$136,990 QoQ

Shares Held

19,000

0.0% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#90

of 223 holders

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,321,580 across 4 Drug Manufacturers - Specialty & Generic names. HROW ranks #2 (34.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	15,000	$1,195,950
2	HROW	Harrow, Inc. This page	19,000	$806,930
3	AQST	Aquestive Therapeutics, Inc.	70,000	$291,200
4	RMTI	Rockwell Medical, Inc.	5,000	$27,500

All Filings in HROW

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$806,930	19,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$669,940	19,000	+90.0%	Shares	Sole	2026-05-15
2025-12-31	$490,000	10,000	-34.1%	Shares	Sole	2026-02-17
2023-09-30	$217,992	15,170	-0.0%	Shares	Sole	2023-11-13
2023-06-30	$288,970	15,177	0.0%	Shares	Sole	2023-08-14
2023-03-31	$321,145	15,177	-45.2%	Shares	Sole	2023-05-12
2022-12-31	$408,866	27,701	-0.3%	Shares	Sole	2023-02-14
2022-09-30	$335,425	27,790	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.